Long-term Efficacy of Trilostane for Cushing's Syndrome due to Adrenocorticotropin-Independent Bilateral Macronodular Adrenocortical Hyperplasia

被引:9
作者
Obata, Yoshinari [1 ]
Yamada, Yuya [1 ]
Baden, Megu Yamaguchi [1 ]
Hosokawa, Yoshiya [1 ]
Saisho, Kenji [1 ]
Tamba, Sachiko [1 ]
Yamamoto, Koji [1 ]
Matsuzawa, Yuji [1 ]
机构
[1] Sumitomo Hosp, Dept Endocrinol & Metab, Osaka, Japan
关键词
adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia (AIMAH); Cushing's syndrome; trilostane; ADRENAL-HYPERPLASIA; HORMONE-RECEPTORS; UNILATERAL ADRENALECTOMY; FOLLOW-UP; AIMAH; THERAPY; SUBTYPE; GLANDS;
D O I
10.2169/internalmedicine.50.5578
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 66-year-old man with Cushing's syndrome due to adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia (AIMAH) was treated for 7 years with trilostane, a 3 beta-hydroxysteroid dehydrogenase inhibitor. Administration of trilostane reduced the serum cortisol level to around the upper limit of normal for 7 years, and symptoms of excessive glucocorticoid production (such as moon face and obesity) were gradually improved. On the other hand, the size of both adrenal glands gradually increased despite treatment with trilostane. Though trilostane therapy could not prevent adrenal growth, it did suppress cortisol secretion over the long term, so it might be a reasonable option for AIMAH in addition to adrenalectomy.
引用
收藏
页码:2621 / 2625
页数:5
相关论文
共 23 条
[1]   ADRENOCORTICOTROPIC HORMONE INDEPENDENT BILATERAL ADRENOCORTICAL MACRONODULAR HYPERPLASIA AS A DISTINCT SUBTYPE OF CUSHINGS-SYNDROME - ENZYME HISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY OF 4 CASES WITH A REVIEW OF THE LITERATURE [J].
AIBA, M ;
HIRAYAMA, A ;
IRI, H ;
ITO, Y ;
FUJIMOTO, Y ;
MABUCHI, G ;
MURAI, M ;
TAZAKI, H ;
MARUYAMA, H ;
SARUTA, T ;
SUDA, T ;
DEMURA, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (03) :334-340
[2]   Aberrant receptor-mediated Cushing's syndrome [J].
Bertagna, X ;
Groussin, L ;
Luton, JP ;
Bertherat, J .
HORMONE RESEARCH, 2003, 59 :99-103
[3]  
Daidoh H, 1998, CLIN ENDOCRINOL, V49, P403
[4]   The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH) [J].
Iacobone, Maurizio ;
Albiger, Nora ;
Scaroni, Carla ;
Mantero, Franco ;
Fassina, Ambrogio ;
Viel, Giovanni ;
Frego, Mauro ;
Favia, Gennaro .
WORLD JOURNAL OF SURGERY, 2008, 32 (05) :882-889
[5]   A case of ACTH-independent bilateral macronodular adrenal hyperplasia successfully treated by subtotal resection of the adrenal glands: Four-year follow-up [J].
Kageyama, Y ;
Ishizaka, K ;
Iwashina, M ;
Sasano, H ;
Kihara, K .
ENDOCRINE JOURNAL, 2002, 49 (02) :227-229
[6]   CUSHINGS SYNDROME - NODULAR CORTICAL HYPERPLASIA OF ADRENAL GLANDS WITH CLINICAL + PATHOLOGICAL FEATURES SUGGESTING ADRENOCORTICAL TUMOR [J].
KIRSCHNER, MA ;
POWELL, RD ;
LIPSETT, MB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1964, 24 (10) :947-+
[7]   TREATMENT OF CUSHINGS-SYNDROME WITH TRILOSTANE (WIN-24,540), AN INHIBITOR OF ADRENAL-STEROID BIOSYNTHESIS [J].
KOMANICKY, P ;
SPARK, RF ;
MELBY, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (05) :1042-1051
[8]   Cushing's syndrome variants secondary to aberrant hormone receptors [J].
Lacroix, A ;
Baldacchino, V ;
Bourdeau, I ;
Hamet, P ;
Tremblay, J .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (08) :375-382
[9]   Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome [J].
Lacroix, A ;
N'Diaye, N ;
Tremblay, J ;
Hamet, P .
ENDOCRINE REVIEWS, 2001, 22 (01) :75-110
[10]   Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. [J].
Lacroix, A ;
Hamet, P ;
Boutin, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1577-1581